Symposium
7th INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES
Amsterdam, The Netherlands, March 23-25, 2009
TAT 2009 has been granted accreditation by the European Society for Medical Oncology (ESMO) and the European Accreditation Council for Continuing Medical Education (EACCME).
ESMO has assigned 16 Category 1 ESMO-MORA points tot the TAT 2009 program. The ESMO Medical Oncologist’s Recertification Approval (MORA) is a CME certificate that allows ESMO members to remain certified in medical oncology.
The ‘ACOE’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The ‘7th INTERNATIONAL SYMPOSIUM ON TARGETED ANTICANCER THERAPIES’ is designated for a maximum of 17 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME credits are recognized by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA Category 1 credit, contact the AMA.
TAT 2009 flyer (n.a.) |
Online registration (n.a.) |
Abstracts submission (n.a.) |
Hotel reservation (n.a.) |
Venue and maps (n.a.) |
Travel and Visa (n.a.) |
Travel grants (n.a.) |
Speakers’ guidelines (n.a.) |
Poster guidelines (n.a.) |
FAQs (n.a.) |
| MDICT Task Force |
| Contact us |
| TAT 2010 |
